Log In
BCIQ
Print this Print this
 

Ribasphere, ribavirin

  Manage Alerts
Collapse Summary General Information
Company Kadmon Holdings Inc.
DescriptionNucleoside analogue in combination with peginterferon alfa-2a
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat chronic hepatitis C (CHC) virus infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today